⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29327292 | 0.81 | — | — | |
| SCHEMBL5653455 | 0.68 | — | — | |
| SCHEMBL9911999 | 0.62 | — | — | |
| SCHEMBL6120904 | 0.62 | — | — | |
| SCHEMBL18811636 | 0.57 | — | — | |
| SCHEMBL753430 | 0.57 | — | — | |
| SCHEMBL13282717 | 0.57 | — | — | |
| SCHEMBL16264723 | 0.57 | — | — | |
| SCHEMBL25330456 | 0.57 | DAO (0.32) | — | |
| SCHEMBL31292592 | 0.55 | DAO (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2488513-B1 | 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases | AC IMMUNE SA (CH) | 2017-12-27 | — | — | EP | disclosed |